Jorge DiMartino
2022
In 2022, Jorge DiMartino earned a total compensation of $1.8M as Chief Medical Officer and Executive Vice President, Clinical Development at Kronos Bio, a 175% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,500 |
|---|---|
| Option Awards | $434,052 |
| Salary | $455,000 |
| Stock Awards | $729,630 |
| Other | $2,185 |
| Total | $1,757,367 |
DiMartino received $729.6K in stock awards, accounting for 42% of the total pay in 2022.
DiMartino also received $136.5K in non-equity incentive plan, $434.1K in option awards, $455K in salary and $2.2K in other compensation.
Rankings
In 2022, Jorge DiMartino's compensation ranked 1,963rd out of 5,760 executives tracked by ExecPay. In other words, DiMartino earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,963 out of 5,760 | 66th |
Division Manufacturing | 1,046 out of 3,136 | 67th |
Major group Chemicals And Allied Products | 444 out of 1,422 | 69th |
Industry group Drugs | 407 out of 1,323 | 69th |
Industry Pharmaceutical Preparations | 295 out of 969 | 70th |
Source: SEC filing on April 27, 2023.
DiMartino's colleagues
We found two more compensation records of executives who worked with Jorge DiMartino at Kronos Bio in 2022.